240 related articles for article (PubMed ID: 32526159)
1. Clostridioides difficile Senses and Hijacks Host Heme for Incorporation into an Oxidative Stress Defense System.
Knippel RJ; Wexler AG; Miller JM; Beavers WN; Weiss A; de Crécy-Lagard V; Edmonds KA; Giedroc DP; Skaar EP
Cell Host Microbe; 2020 Sep; 28(3):411-421.e6. PubMed ID: 32526159
[TBL] [Abstract][Full Text] [Related]
2. Heme sensing and detoxification by HatRT contributes to pathogenesis during Clostridium difficile infection.
Knippel RJ; Zackular JP; Moore JL; Celis AI; Weiss A; Washington MK; DuBois JL; Caprioli RM; Skaar EP
PLoS Pathog; 2018 Dec; 14(12):e1007486. PubMed ID: 30576368
[TBL] [Abstract][Full Text] [Related]
3. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
[TBL] [Abstract][Full Text] [Related]
4. Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing.
Marreddy RKR; Olaitan AO; May JN; Dong M; Hurdle JG
Microbiol Spectr; 2021 Oct; 9(2):e0044821. PubMed ID: 34468187
[TBL] [Abstract][Full Text] [Related]
5. ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity.
Zackular JP; Knippel RJ; Lopez CA; Beavers WN; Maxwell CN; Chazin WJ; Skaar EP
mSphere; 2020 Mar; 5(2):. PubMed ID: 32161145
[No Abstract] [Full Text] [Related]
6. The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile.
Pokhrel A; Poudel A; Castro KB; Celestine MJ; Oludiran A; Rinehold AJ; Resek AM; Mhanna MA; Purcell EB
J Bacteriol; 2020 Sep; 202(19):. PubMed ID: 32661079
[TBL] [Abstract][Full Text] [Related]
7. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.
Cribas ES; Denny JE; Maslanka JR; Abt MC
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649048
[TBL] [Abstract][Full Text] [Related]
8. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.
Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB
Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357
[TBL] [Abstract][Full Text] [Related]
9. Shifts in the Gut Metabolome and
Fletcher JR; Erwin S; Lanzas C; Theriot CM
mSphere; 2018; 3(2):. PubMed ID: 29600278
[TBL] [Abstract][Full Text] [Related]
10.
Furtado KL; Plott L; Markovetz M; Powers D; Wang H; Hill DB; Papin J; Allbritton NL; Tamayo R
mSphere; 2024 Jun; 9(6):e0008124. PubMed ID: 38837404
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the genes encoding surface associated proteins of Clostridioides difficile isolates.
Aliramezani A; Talebi M; Douraghi M
Infect Genet Evol; 2020 Dec; 86():104598. PubMed ID: 33080382
[TBL] [Abstract][Full Text] [Related]
12. C. difficile exploits a host metabolite produced during toxin-mediated disease.
Pruss KM; Sonnenburg JL
Nature; 2021 May; 593(7858):261-265. PubMed ID: 33911281
[TBL] [Abstract][Full Text] [Related]
13. The Clostridium difficile spo0A gene is a persistence and transmission factor.
Deakin LJ; Clare S; Fagan RP; Dawson LF; Pickard DJ; West MR; Wren BW; Fairweather NF; Dougan G; Lawley TD
Infect Immun; 2012 Aug; 80(8):2704-11. PubMed ID: 22615253
[TBL] [Abstract][Full Text] [Related]
14. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
Theriot CM; Young VB
Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Colonization Resistance Against Clostridioides difficile.
Pike CM; Theriot CM
J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
[TBL] [Abstract][Full Text] [Related]
16.
Weiss A; Lopez CA; Beavers WN; Rodriguez J; Skaar EP
Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34908523
[No Abstract] [Full Text] [Related]
17.
Cheng JKJ; Unnikrishnan M
Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
[No Abstract] [Full Text] [Related]
18. Rho factor mediates flagellum and toxin phase variation and impacts virulence in Clostridioides difficile.
Trzilova D; Anjuwon-Foster BR; Torres Rivera D; Tamayo R
PLoS Pathog; 2020 Aug; 16(8):e1008708. PubMed ID: 32785266
[TBL] [Abstract][Full Text] [Related]
19. Regulation of para-cresol production in Clostridioides difficile.
Harrison MA; Strahl H; Dawson LF
Curr Opin Microbiol; 2022 Feb; 65():131-137. PubMed ID: 34856509
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of fidaxomicin on biofilm formation in Clostridioides difficile.
Hamada M; Yamaguchi T; Ishii Y; Chono K; Tateda K
J Infect Chemother; 2020 Jul; 26(7):685-692. PubMed ID: 32224190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
